Logo (Actavis) 3093 Logo (Actavis) 3093 Pill: blue, capsule/oblong, 23mm
The pill with imprint Logo (Actavis) 3093 Logo (Actavis) 3093 (Blue, Capsule/Oblong, 23mm) has been identified as Morphine Sulfate Extended-Release 120 mg and is used for Chronic Pain, Neonatal Abstinence Syndrome, and Pain. It belongs to the drug class Opioids (narcotic analgesics) and is classified as CSA Schedule 2 (High potential for abuse).
Images for Logo (Actavis) 3093 Logo (Actavis) 3093
Morphine Sulfate Extended-Release
- Imprint
- Logo (Actavis) 3093 Logo (Actavis) 3093
- Strength
- 120 mg
- Color
- Blue
- Size
- 23.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Opioids (narcotic analgesics)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Actavis Elizabeth LLC
- National Drug Code (NDC)
- 00228-3093
- Inactive Ingredients
-
diethyl phthalate,
ethylcellulose,
gelatin,
methacrylic acid - methyl methacrylate copolymer (1:1),
polyethylene glycol,
sucrose,
magnesium silicate,
titanium dioxide,
FD&C Blue No. 1,
ferrosoferric oxide,
butyl alcohol,
alcohol,
isopropyl alcohol,
potassium hydroxide,
propylene glycol,
water,
shellac,
ammonia
Note: Inactive ingredients may vary.
See also:
More about morphine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (367)
- Drug images
- Latest FDA alerts (13)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
Patient resources
Other brands
MS Contin, Roxanol, Kadian, RMS, ... +10 more
Professional resources
- Morphine Sulfate monograph
- Morphine ER (FDA)
- Morphine Extended Release Capsules (FDA)
- Morphine Injection (FDA)
- Morphine Oral Solution (FDA)
Other brands
MS Contin, Kadian, Duramorph, Astramorph PF, ... +4 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.